Overview

Dexmedetomidine Infusion as an Analgesic Adjuvant During Laparoscopic Cholecystectomy

Status:
Unknown status
Trial end date:
2017-10-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of this study was to evaluate efficacy and safety of dexmedetomidine infusion during laparoscopic cholecystectomy. The randomized, single-center, controlled study was carried out from May 2016 to June 2017 at department of surgery, anesthesiology and intensive care, Postgraduate Institute of Bogomolets National Medical University.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Bogomolets National Medical University
Treatments:
Analgesics
Dexmedetomidine
Criteria
Inclusion Criteria:

- patients elected for laparoscopic cholecystectomy

- age between 18 and 79 years

- either sex

- ASA physical status I to II

Exclusion Criteria:

- age outside the specified range

- pregnancy or lactation

- severe systemic disease (ASA III physical status or more)

- patients on b-blockers or calcium channel blockers